Behavioral Health Group (BHG) is the largest group of outpatient opioid treatment and recovery centers delivering comprehensive evidence-based medical and behavioral therapies for tailored treatment in the United States. The Company is among very few providers who leverage all three FDA-approved medications with levels of counseling and therapy to achieve industry leading results. The Company’s approach to personalized opioid treatment and recovery restores lives, strengthens families and rejuvenates the communities served. Operations are conducted at 60 locations across 14 states, each with full Federal, State and DEA licenses and Joint Commission accreditation. Headquartered in Dallas, TX, BHG has multiple growth levers including:
Acquisition of smaller regional providers of addiction treatment and bolting the resulting operations into the BHG operations.
Contracting with third party payors to enable patients to take advantage of insurance coverage.
Expanding the scope and scale of the clinical offering to ensure patients have the full spectrum of evidence-based treatment available.
Pursuing advocacy at state and federal levels to ensure funding and reimbursement adequately addresses the largest public health crisis in a generation.
The Company is expanding into all segments of outpatient addiction treatment and getting in network with all third-party payors. The Company’s current payor mix is approximately 50% self-pay and 50% third party. With new reimbursement coming into the market from commercial payors and government sources, it is expected that the payor mix will be 20% self-pay and 80% third party sources in the next 18 months.
BHG’s mission is to be the best-in-class full-service provider of outpatient addiction treatment by producing superior patient outcomes. This goal is accomplished by providing each person who enters their programs with a medically based treatment experience in accordance with the organization’s governing bodies. BHG’s treatment programs rehabilitate those aspects of the person which are suffering; build upon the strengths of that person; protect that person’s rights to privacy, respect and dignity; and assist in the development of a better quality of life. In doing so, the Company improves the lives and communities of those treated and builds a strong company that serves its patients and communities over the long term.
BHG core values:
Compassion – We know that addiction is a disease and we meet each patient where they are in their recovery.
Committed – We are dedicated to helping every patient achieve long-term addiction recovery.
Proven – We have the quantitative and qualitative data to support our positive outcomes.
Meaningful and measurable success:
99% of BHG patients report that their mental health and quality of life have improved since admission.
More than 60% of unemployed patients obtain employment after one year of treatment.
97% of patients would recommend BHG to a friend or family member suffering from opioid addiction.
BHG has a history of strong financial investment. Prior to December 2018, BHG was owned by Frontenac, a private equity firm based in Chicago. Frontenac led a recapitalization of BHG in 2011 and helped develop and support an aggressive growth plan that resulted in the company more than tripling in size. Highlights include transformative investments in the senior and field-level leadership teams, expanding the geographic footprint from 20 to 50+ treatment centers via acquisitions and new facility openings, and building an expanded base of commercial and governmental payor relationships.
BHG successfully recapitalized the company with The Vistria Group in December 2018. The Vistria Group is a Chicago-based private investment firm focused on middle-market companies in the healthcare, education, and financial services industries. Vistria’s team is comprised of highly experienced operators and investors with proven track records of partnering with management teams to build innovative, market-leading companies.
Vistria seeks investment opportunities with strong financial return and social impact profiles. They are comfortable investing in highly regulated sectors and have deep relationships with many of the largest health plans in the U.S.
The Chief Medical Officer (CMO) will report to the Chief Executive Officer and be a member of the senior leadership team. S/He will be responsible for working with the Vice President of Clinical and Regulatory Affairs, operations leaders, medical staff, and external stakeholders to transform BHG into a full-service outpatient addiction treatment company with the majority of revenue coming from third party payers. BHG is already well along in this transition with OBOT and IOP service offerings with about half the revenue currently coming from third party sources. The objective is to build a more high-quality medical service model that addresses patient and third-party payor needs for high quality, cost effective care.
The Chief Medical Officer will:
Position BHG as a premiere provider of outpatient addiction treatment
Establish BHG range of services to include all FDA approved medications for treating addiction, full range of counseling services (IOP, Enhanced Counseling, Case Management, Care Coordination, Outpatient Counseling, etc.).
Establish BHG’s range of medical interventions – define the range of medical services and conditions treated to meet patient needs in the context of what BHG should and can provide. Consideration given to which, if any, co-occurring medical and psychiatric conditions are in-scope for the company’s operations.
Define clinical pathways for different patient profiles.
Define outcome metrics and how the company defines, measures, and reports on quality to stakeholders internally, to regulators, to patients, to teammates, and to third-party payers.
Establish a medical advisory/leadership group of internal and external (if appropriate) clinicians and articulate The BHG Way.
Third Party Payers
Work with the SVP of Contracting to articulate and sell a value proposition for third-party payors that positions BHG as the provider of choice.
Meet with Medical Directors of third-party payers and ensure clinicians from both organizations are working collaboratively.
Help to foster partnerships between payers and BHG.
Identify referral channels between BHG and payers.
Educate payers on how to identify patients appropriate for referral and ensure BHG is structured properly to accept those referrals.
Communicate outcomes and value to payers on a routine basis.
Training and Development
Train BHG physicians and drive adoption of The BHG Way throughout the organization.
Work with Chief Development Officer to identify and recruit new physicians to the company’s operations (in existing facilities and in connection with acquisitions).
Train new physicians in how to treat opioid use disorder and help expand number of physicians and providers to achieve DATA 2000 waiver.
Work with Chief Development Officer to identify acquisition opportunities and participate in medical diligence.
Play role (TBD) in expansion of the company’s goal of establishing freestanding OBOT Clinics and how that fits into the overall clinical and business model.
Play role (TBD) in “Friendly Physician PC” structure that allows the company to employ new physicians.
Work with VP Regulatory Compliance and entire compliance team to build relationships with regulators and position BHG as a high quality, comprehensive provider of addiction treatment services.
Work with VP Regulatory Compliance on Joint Commission Accreditation standards especially as relates to quality assurance and quality improvement programs and activities.
Work with the Director of Clinical Services to ensure clinical staff are documenting services appropriately and consistently with requirements of all third-party payors.
Professional and Public Relations
Serve as Medical Ambassador for the company in the professional and public sphere.
Work with VP Marketing to develop literature and other educational materials for distribution to referring medical community and patients directly.
Consider opportunities to conduct research and publish research findings that advance medical treatment, produce improved clinical outcomes and position BHG as a thought leader in the addiction treatment field.
Seek opportunities to work with sponsors of clinical research and utilize BHG platform for approved trials.
YEAR ONE CRITICAL SUCCESS FACTORS
Define BHG Medical Model – The BHG Way.
Define BHG clinical pathways.
Define clinical KPI’s and outcomes measures and tracking.
Establish medical advisory board.
BHG seeks a seasoned and mature professional who is a thought leader in the emerging addiction treatment market with board certification. Ideally the candidate will have experience in a physician leadership capacity with current or recent past academic medical center experience. The ideal candidate will have a part-time role in treating patients, but not an absolute requirement. The location may be flexible especially if this is a part-time practicing physician.
Candidates for this position will have effective communication skills and a proven track record of managing relationships well both internally and externally. S/he will be comfortable working in a collaborative and consensus building environment and can work with a variety of constituents; s/he must be diplomatic, but self-assured. The successful candidate must have vision, initiative, stamina, assertiveness, strong interpersonal skills, and a results orientation. S/he must be strategic and able to see the big picture as well as have a strong detail orientation. The ability to achieve financial and business objectives is critical.
The successful candidate must be a quick study and be able to gain a thorough understanding of BHG’s services and market potential. The candidate must also be politically astute with high ethical standards and be a person who elicits respect from others. It is critical in this position that the candidate exhibits behaviors consistent with BHG’s mission.
This person will be bright, positive, up-beat, have a can-do attitude with a bias to action and an assertive approach in the marketplace. A team player with a strong work ethic, the Chief Medical Officer will have a compelling need to get things done, be self-assured with a contained ego, and have a professional respect for all team members.
An MD or DO degree with board certification in a Addiction Medicine is required. An active and current state medical license without encumbrances is required. An MBA degree is a plus.
BHG will provide an attractive compensation package, including a competitive base salary, performance bonus, and equity.
Internal Number: 1
About Behavioral Health Group (BHG)
Behavioral Health Group (BHG) is the largest network of Joint Commission-accredited outpatient opioid treatment and recovery centers in the U.S., delivering comprehensive, personalized evidence-based medical and behavioral therapies for individuals with opioid use disorder. With 64 locations across 14 states, BHG provides services to thousands of individuals and their communities across the country.